Literature DB >> 31901936

The year in cardiology: heart failure.

John G F Cleland1,2,3, Alexander R Lyon2,4, Theresa McDonagh5,6, John J V McMurray3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31901936      PMCID： PMC7084174          DOI： 10.1093/eurheartj/ehz949

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  154 in total

1.  Lung ultrasound: monitoring congestion in patients with heart failure.

Authors:  Elke Platz; Scott D Solomon; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2019-11-08       Impact factor: 15.534

2.  Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.

Authors:  Suzanne V Arnold; Khaja M Chinnakondepalli; John A Spertus; Elizabeth A Magnuson; Suzanne J Baron; Saibal Kar; D Scott Lim; Jacob M Mishell; William T Abraham; JoAnn A Lindenfeld; Michael J Mack; Gregg W Stone; David J Cohen
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

3.  Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study.

Authors:  Anukul Ghimire; Nowell Fine; Justin A Ezekowitz; Jonathan Howlett; Erik Youngson; Finlay A McAlister
Journal:  Eur Heart J       Date:  2019-07-01       Impact factor: 29.983

4.  Association of Ambulatory Hemodynamic Monitoring of Heart Failure With Clinical Outcomes in a Concurrent Matched Cohort Analysis.

Authors:  Jacob Abraham; Rupinder Bharmi; Orvar Jonsson; Guilherme H Oliveira; Andre Artis; Ali Valika; Robert Capodilupo; Philip B Adamson; Gregory Roberts; Nirav Dalal; Akshay S Desai; Raymond L Benza
Journal:  JAMA Cardiol       Date:  2019-06-01       Impact factor: 14.676

5.  Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure.

Authors:  Elke Platz; Pardeep S Jhund; Nicolas Girerd; Emanuele Pivetta; John J V McMurray; W Frank Peacock; Josep Masip; Francisco Javier Martin-Sanchez; Òscar Miró; Susanna Price; Louise Cullen; Alan S Maisel; Christiaan Vrints; Martin R Cowie; Salvatore DiSomma; Hector Bueno; Alexandre Mebazaa; Danielle M Gualandro; Mucio Tavares; Marco Metra; Andrew J S Coats; Frank Ruschitzka; Petar M Seferovic; Christian Mueller
Journal:  Eur J Heart Fail       Date:  2019-06-19       Impact factor: 15.534

6.  Role of cardioprotective agents on chemotherapy-induced heart failure: A systematic review and network meta-analysis of randomized controlled trials.

Authors:  Xinye Li; Yanda Li; Tiansong Zhang; Xingjiang Xiong; Nian Liu; Bing Pang; Yanfei Ruan; Yonghong Gao; Hongcai Shang; Yanwei Xing
Journal:  Pharmacol Res       Date:  2019-11-29       Impact factor: 7.658

7.  Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial.

Authors:  Stefan D Anker; Javed Butler; Gerasimos S Filippatos; Waheed Jamal; Afshin Salsali; Janet Schnee; Karen Kimura; Cordula Zeller; Jyothis George; Martina Brueckmann; Faiez Zannad; Milton Packer
Journal:  Eur J Heart Fail       Date:  2019-09-16       Impact factor: 15.534

8.  Exercise-based cardiac rehabilitation for adults with heart failure.

Authors:  Linda Long; Ify R Mordi; Charlene Bridges; Viral A Sagar; Edward J Davies; Andrew Js Coats; Hasnain Dalal; Karen Rees; Sally J Singh; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2019-01-29

9.  Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.

Authors:  Li Shen; Rasmus Rørth; Deborah Cosmi; Søren Lund Kristensen; Mark C Petrie; Franco Cosmi; Roberto Latini; Lars Køber; Inder S Anand; Peter E Carson; Christopher B Granger; Michel Komajda; Robert S McKelvie; Scott D Solomon; Lidia Staszewsky; Karl Swedberg; Thao Huynh; Michael R Zile; Pardeep S Jhund; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2019-07-04       Impact factor: 15.534

10.  Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction.

Authors:  Rasmus Rørth; Pooja Dewan; Søren Lund Kristensen; Pardeep S Jhund; Mark C Petrie; Lars Køber; John J V McMurray
Journal:  Clin Res Cardiol       Date:  2019-01-28       Impact factor: 5.460
View more
  3 in total

1.  Sex-specific impact of diabetes mellitus on left ventricular systolic function and prognosis in heart failure.

Authors:  Jun-Bean Park; Goo-Yeong Cho; Soongu Kwak; In-Chang Hwang; Jin Joo Park; Jae-Hyeong Park
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

2.  Left ventricular function and coronary microcirculation in patients with mild reduced ejection fraction after STEMI.

Authors:  Lan Wang; Wenying Jin; Yuliang Ma; Tiangang Zhu; Jian Liu; Hong Zhao; Jing Wang; Mingyu Lu; Chengfu Cao; Bailin Jiang
Journal:  BMC Cardiovasc Disord       Date:  2022-09-25       Impact factor: 2.174

3.  The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial.

Authors:  John G F Cleland; João Pedro Ferreira; Beatrice Mariottoni; Pierpaolo Pellicori; Joe Cuthbert; Job A J Verdonschot; Johannes Petutschnigg; Fozia Z Ahmed; Franco Cosmi; Hans-Peter Brunner La Rocca; Mamas A Mamas; Andrew L Clark; Frank Edelmann; Burkert Pieske; Javed Khan; Ken McDonald; Philippe Rouet; Jan A Staessen; Blerim Mujaj; Arantxa González; Javier Diez; Mark Hazebroek; Stephane Heymans; Roberto Latini; Stéphanie Grojean; Anne Pizard; Nicolas Girerd; Patrick Rossignol; Tim J Collier; Faiez Zannad
Journal:  Eur Heart J       Date:  2021-02-11       Impact factor: 29.983
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.